Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on knowledge of ...
Australia's NEXTDC inks MoU with OpenAI to develop AI infrastructure in Sydney, shares jump NEXTDC Ltd said on Friday it inked a memorandum of understanding with ChatGPT maker OpenAI to collaborate on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback